Schedule 13G/A Filing by The Vanguard Group for Integra LifeSciences Holdings Corp

This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership. The Vanguard Group, a registered investment advisor, reports that it holds 0 shares of Integra LifeSciences Holdings Corp common stock. This filing follows an internal realignment within The Vanguard Group, Inc. on January 12, 2026, which resulted in certain subsidiaries and business divisions reporting beneficial ownership separately. As a result, The Vanguard Group, Inc. no longer claims beneficial ownership of securities held by these disaggregated entities. The filing states that Vanguard Group, including its managed accounts, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the reported securities. However, no single person or entity other than Vanguard Group has an interest exceeding 5% in the securities.